Last reviewed · How we verify

PEG then Senna — Competitive Intelligence Brief

PEG then Senna (PEG then Senna) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Laxative combination (osmotic + stimulant). Area: Gastroenterology.

marketed Laxative combination (osmotic + stimulant) Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

PEG then Senna (PEG then Senna) — British Columbia Cancer Agency. PEG (polyethylene glycol) followed by Senna works as a bowel preparation regimen that uses an osmotic laxative to cleanse the colon, followed by a stimulant laxative to promote evacuation.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
PEG then Senna TARGET PEG then Senna British Columbia Cancer Agency marketed Laxative combination (osmotic + stimulant)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Laxative combination (osmotic + stimulant) class)

  1. British Columbia Cancer Agency · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). PEG then Senna — Competitive Intelligence Brief. https://druglandscape.com/ci/peg-then-senna. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: